Eli Lilly outlays $7.8bn to acquire sleep drug biotech Centessa

Wednesday, April 1, 2026Robert BarrieView original

Whether the deal reaches its full value hinges on US regulatory milestones for Centessa’s lead candidate, cleminorexton.

Read the full article on the original site.